Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation

Atherosclerosis

Volumn 159, Issue 2, 2001, Pages 325-332

  Dulakk, Józef ^a,b   Józkowicz, Alicja ^c,d   Dichtl, Wolfgang ^a   Alber, Hannes ^a   Schwarzacher, Severin P ^a   Pachinger, Otmar ^a   Weidinger, Franz ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY OF VIENNA   (Austria)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Angiogenesis; Atherosclerosis; Endothelium; Nitric oxide; Transcription factors

Indexed keywords

7 OXOCHOLESTEROL; INTERLEUKIN 1BETA; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENETIC TRANSCRIPTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE; VIROGENESIS;

ANALYSIS OF VARIANCE; ANIMALS; ENDOTHELIAL GROWTH FACTORS; HUMANS; KETOCHOLESTEROLS; LYMPHOKINES; LYSOPHOSPHATIDYLCHOLINES; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PROBABILITY; RATS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035202707     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00520-2     Document Type: Article

References (43)

1. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
2. Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells
3. Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells
4. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia
5. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells
6. Nitric oxide increases the synthesis of vascular endothelial growth factor in vascular smooth muscle cells
7. Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise
8. Production of vascular endothelial growth factor by murine macrophages: Regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway
9. Induction of inducible nitric oxide synthase and its corresponding tetrahydrobiopterin-cofactor-synthesizing enzyme GTP-cyclohydrolase I during cutaneous wound repair
10. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells
11. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells
12. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide
13. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries
14. VEGF-nitric oxide reciprocal regulation
15. 2 in endothelial cells via p42/44 mitogen activated protein kinases
16. Coronary vasospasm in humans: The role of atherosclerosis and of impaired endothelial vasodilator function
17. The pathogenesis of atherosclerosis: A perspective for the 1990s
18. Nitric oxide synthase: Role in the genesis of vascular disease
19. Atherogenic lipids and endothelial dysfunction: Mechanisms in the genesis of ischemic syndromes
20. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
21. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
22. Catheter-mediated VEGF gene transfer to human lower limb arteries after PTA
23. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
24. Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
25. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice
26. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions
27. Regulation of vascular endothelial growth factor and nitric oxide generation in vascular smooth muscle cells by low density lipoprotein
28. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase
29. Expression of beta-galactosidase gene and endothelial nitric oxide synthase gene in rat vascular smooth muscle cells after in vitro lipotransfection
30. Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSG5VEGF plasmids in vascular smooth muscle cells
31. Single-step method of RNA isolation by acid guanidinum-thiocynate-phenol-chloroform extraction
32. Regulation of inducible nitric oxide synthase (iNOS) and cyclohydrolase GTP I (GTP-CH I) gene expression by ox-LDL in rat vascular smooth muscle cells
33. Oxidized low density lipoprotein inhibits inducible nitric oxide synthase, GTP cyclohydrolase I and transforming growth factor β gene expression in rat macrophages
34. Copper and cell-oxidized low-density lipoprotein induces activator protein 1 in fibroblasts, endothelial and smooth muscle cells
35. Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor-kappa B in human vascular smooth muscle cells
36. Expression of the peroxisome proliferator-activated receptor gamma (PPAR-γ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
37. Ligands of peroxisome proliferator-activated receptor-γ increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages
38. Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells
39. Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins
40. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: Correlation with induction of heme oxygenase 1
41. Peroxisome proliferator-activated receptor-γ ligands inhibit nitric oxide synthesis in vascular smooth muscle cells
42. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages
43. Vascular protection: A novel nonangiogenic cardiovascular role for vascular endothelial growth factor